(Q38044995)

27 August 2017

title

The burden of moderate to severe psoriasis: an overview (English)

1 reference

27 August 2017

4

1 reference

27 August 2017

Giovanna Raho

1

1 reference

27 August 2017

Daniela Mihajlova Koleva

series ordinal

2

1 reference

27 August 2017

Livio Garattini

series ordinal

3

1 reference

27 August 2017

publication date

1 November 2012

1 reference

27 August 2017

1 reference

27 August 2017

volume

30

1 reference

27 August 2017

issue

11

1 reference

27 August 2017

page(s)

1005-1013

1 reference

Epidemiology of psoriasis

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2165%2F11591580-000000000-00000

The clinical spectrum of psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591580-000000000-00000

Assessing the impact of psoriasis and the relevance of qualitative research

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591580-000000000-00000

Classification and diagnostic criteria for psoriatic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591580-000000000-00000

Complexity of the association between psoriasis and comorbidities

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591580-000000000-00000

Epidemiology of comorbidities in psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591580-000000000-00000

What are the best outcome measures for assessing quality of life in plaque type psoriasis? A systematic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591580-000000000-00000

Traditional therapies in the management of moderate to severe chronic plaque psoriasis: an assessment of the benefits and risks.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591580-000000000-00000

Biologics in the treatment of psoriasis: clinical and economic overview

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591580-000000000-00000

The psychosocial burden of psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591580-000000000-00000

Psoriasis causes as much disability as other major medical diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591580-000000000-00000

The contribution of perceptions of stigmatisation to disability in patients with psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591580-000000000-00000

Lifestyle of Nordic people with psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591580-000000000-00000

Impact of psoriasis on health-related quality of life decreases over time: an 11-year prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591580-000000000-00000

Association between poorer quality of life and psychiatric morbidity in patients with different dermatological conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591580-000000000-00000

Psoriasis: epidemiology, clinical features, and quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591580-000000000-00000

Quality of life in patients with psoriasis and psoriasis arthritis with a special focus on stigmatization experience

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591580-000000000-00000

Significance of the stigmatization experience of psoriasis patients: a 1-year follow-up of the illness and its psychosocial consequences in men and women.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591580-000000000-00000

Psoriasis has a major secondary impact on the lives of family members and partners

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591580-000000000-00000

Cost-of-illness in patients with moderate and severe chronic psoriasis vulgaris in Germany.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591580-000000000-00000

Costs and quality of life in patients with moderate to severe plaque-type psoriasis in Germany: a multi-center study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591580-000000000-00000

Moderate and severe plaque psoriasis: cost-of-illness study in Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591580-000000000-00000

Economic burden of psoriasis compared to the general population and stratified by disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591580-000000000-00000

Recent trends in systemic psoriasis treatment costs

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591580-000000000-00000

National registries of systemic treatment for psoriasis and the European 'Psonet' initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591580-000000000-00000

Suicidal ideation in psoriasis

21 January 2018

1 reference

12 December 2020

Association of patient-reported psoriasis severity with income and employment

1 reference

12 December 2020

Estimation of cost-of-illness in patients with psoriasis in Switzerland

1 reference

12 December 2020

Are patients with psoriasis undertreated? Results of National Psoriasis Foundation survey

1 reference

12 December 2020

Clinical severity of psoriasis in last 20 years of PUVA study

1 reference

12 December 2020

A prospective evaluation of the cost of psoriasis in Spain (EPIDERMA project: phase II)

1 reference

12 December 2020

Psoriasis: is the impairment to a patient's life cumulative?

1 reference

12 December 2020

Risk of Myocardial Infarction in Patients With Psoriasis

1 reference

12 December 2020

10.2165/11591580-000000000-00000

Identifiers

DOI

1 reference

Dimensions Publication ID

27 August 2017

1027506335

0 references

1 reference